In these years an ouabain -like factor (OLF), structurally similar to cardiac glycoside ouabain, has been isolated in human plasma. OLF has been implicated in states of volume expansion and in essential hypertension, especially as a factor of salt sensitivity of blood pressure. On the other hand, salt sensitivity has been described particularly in low-renin hypertension.
OR-40 IN SALT-SENSITIVE HYPERTENSION STATINS PROTECT END-ORGAN INJURY VIA INCREASED NO PRODUCTION AND DECREASED REACTIVE OXYGEN SPECIES
The balance between nitric oxide (NO), angiotensin (Ang) II and superoxide (O 2 -) is critical for maintenance of cardiovascular homeostasis. Hypertensive Dahl salt-sensitive (DS) rats are NO deficient due to eNOS downregulation and decreased NO bioavailability linked to a functional upregulation of Ang II, which results in increased O 2 Ϫ , endothelial dysfunction, and cardiorenal injury. It has been reported that statins upregulate eNOS, inhibit oxidative stress and downregulate AT1 receptor. Here we investigated whether atorvastatin (ATO, 30 mg/kg/day; by gavage for 10 weeks) would upregulate eNOS, increase NO bioavailability and prevent the increase in O 2 Ϫ in DS rats, thereby reducing end-organ injury. DS rats were divided into 5 groups: NS, fed 0.5% NaCl diet; HS, fed 4% NaCl diet; HSϩATO, fed 4% NaCl diet plus ATO; HS/NS, fed 4% NaCl diet for 6 weeks following 0.5% NaCl diet for 4 weeks; HS/NSϩATO, fed 4% NaCl diet for 6 weeks following 0.5% NaCl diet plus ATO for 4 weeks. HS rats developed hypertension (SBP 200 Ϯ 8 vs 150 Ϯ 2 mmHg in NS; PϽ0.05), impaired endothelium-dependent relaxation to acetylcholine (EDR), functional upregulation of endothelin (ET)-1, left ventricular (LVH, 30%), aortic (23%) hypertrophy, and proteinuria (167%), accompanied by downregulation of aortic eNOS activity (0.7 Ϯ 0.2 vs 1.8 Ϯ 0.3 nmol/min/g protein in NS; PϽ0.05) and increased aortic O 2 Ϫ (2632 Ϯ 316 vs 1176 Ϯ 112 counts/min/mg in NS; PϽ0.05) and plasma 8-F 2 a isoprostanes (97.2 Ϯ 12.3 pg/ml vs 57.3 Ϯ 13 pg/ml in NS, PϽ0.05). ATO (HSϩATO) prevented the decrease in eNOS activity (1.5 Ϯ 0.3 nmol/min/g protein) as well as the increase in O 2 Ϫ (1192 Ϯ 243 counts/min/mg) and plasma 8-F 2 a isoprostanes (58.4 Ϯ 15.2 pg/ml), reduced LVH and proteinuria, and normalized EDR, vascular response to ET-1, and aortic hypertrophy, although reduction in SBP was modest (174 Ϯ 8 mmHg). Switch to NS alone (HS/NS) did not ameliorate SBP (205 Ϯ 7 mmHg), EDR or end-organ injury and minimally reduced O 2 Ϫ production (1974 Ϯ 171 counts/min/mg). Combination of ATO and removal of high salt (HS/NSϩATO) normalized aortic eNOS (1.56 Ϯ 0.17 nmol/min/g protein), as well as SBP (152 Ϯ 2 mmHg), LVH, and proteinuria. These novel findings indicate that in salt-sensitive hypertension the concomitant upregulation of vascular eNOS and inhibition of oxidative stress may importantly contribute to the protection against end-organ injury afforded by statins.
